Scarica l'app Stockscreener
48.52
0.76%
-0.37
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
Ptc Therapeutics Inc Borsa (PTCT) Ultime notizie
Quantinno Capital Management LP Invests $436,000 in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Toronto Dominion Bank Makes New $148.36 Million Investment in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
BNP Paribas Financial Markets Has $465,000 Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
State of Wyoming Buys New Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Two Sigma Investments LP Sells 143,945 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages PTC Therapeutics, Inc. (PTCT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
RNA Targeting Small Molecule Drug Discovery Research Report 2025 - GlobeNewswire Inc.
Analysts Set PTC Therapeutics, Inc. (NASDAQ:PTCT) Price Target at $63.75 - MarketBeat
Woodline Partners LP Acquires Shares of 155,883 PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Millennium Management LLC Has $13.97 Million Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Sold by Bank of America Corp DE - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock Holdings Lifted by ProShare Advisors LLC - MarketBeat
Wells Fargo & Company Increases PTC Therapeutics (NASDAQ:PTCT) Price Target to $74.00 - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Position Cut by Two Sigma Advisers LP - MarketBeat
Voloridge Investment Management LLC Sells 92,168 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Therapeutics (PTCT) Price Target Raised by Wells Fargo | PTCT Stock News - GuruFocus
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
PTCT: Wells Fargo Increases Price Target for PTC Therapeutics | - GuruFocus
Evolving Landscape of Mitochondrial Disease Market: Key Insights of Latest Published Report—Leigh Syndrome, Leber’s Hereditary Optic Neuropathy, MELAS Syndrome, and Thymidine Kinase 2 Deficiency | DelveInsight - GlobeNewswire Inc.
PTC Therapeutics’ SWOT analysis: biotech stock faces pivotal year amid pipeline progress - Investing.com Nigeria
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc.PTCT - Eastern Progress
Nuveen Asset Management LLC Acquires 273,638 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Rafferty Asset Management LLC Reduces Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Lazard Asset Management LLC Has $2.06 Million Stock Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Muscular Dystrophy Treatment Market: Executive Briefing & - openPR.com
Huntington's Disease Pipeline 2025: Groundbreaking Clinical - openPR.com
Those who invested in PTC Therapeutics (NASDAQ:PTCT) three years ago are up 51% - Yahoo Finance
Deutsche Bank AG Has $4.26 Million Stock Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
StockNews.com Downgrades PTC Therapeutics (NASDAQ:PTCT) to Buy - MarketBeat
Point72 Asset Management L.P. Purchases 867,502 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Point72 Hong Kong Ltd Grows Stock Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Transcript : PTC Therapeutics, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 02 - marketscreener.com
14,998 Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) Bought by Graham Capital Management L.P. - MarketBeat
Parkman Healthcare Partners LLC Decreases Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
2025-05-19 | PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:PTCT | Press Release - Stockhouse
MPM Bioimpact LLC Buys 345,052 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages PTC Therapeutics, Inc. (PTCT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results - Quantisnow
PTC Therapeutics (NASDAQ:PTCT) Shares Gap Down – Here’s What Happened - Defense World
Dimensional Fund Advisors LP Invests $4.74 Million in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Holdings Raised by Northern Trust Corp - MarketBeat
Jacobs Levy Equity Management Inc. Sells 659,778 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):